- Previous Close
44.43 - Open
42.74 - Bid --
- Ask --
- Day's Range
42.26 - 43.25 - 52 Week Range
42.26 - 58.10 - Volume
192,363 - Avg. Volume
464,590 - Market Cap (intraday)
43.02B - Beta (5Y Monthly) 0.78
- PE Ratio (TTM)
0.25 - EPS (TTM)
1.69 - Earnings Date May 7, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, solutions, and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services, and digital solutions and applications for managing treatment and therapy. Its Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms. It offers essential technical customer service, such as maintenance and repair; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as digital healthhcare consulting, products, and services. The company was incorporated in 2017 and is headquartered in Forchheim, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.
www.siemens-healthineers.com73,100
Full Time Employees
September 30
Fiscal Year Ends
--
Sector
--
Industry
Recent News: 0PMJ.L
View MorePerformance Overview: 0PMJ.L
Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0PMJ.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0PMJ.L
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
8.76%
Return on Assets (ttm)
3.88%
Return on Equity (ttm)
10.63%
Revenue (ttm)
22.67B
Net Income Avi to Common (ttm)
1.98B
Diluted EPS (ttm)
1.69
Balance Sheet and Cash Flow
Total Cash (mrq)
2.77B
Total Debt/Equity (mrq)
83.83%
Levered Free Cash Flow (ttm)
2.77B